Validation of a model to predict hospitalization due to RSV of infants born at 33-35 weeks' gestation

Journal of Perinatal Medicine

Volumn 38, Issue 4, 2010, Pages 411-417

  Carbonell Estrany, Xavier ^a   Simões, Eric A F ^b   Fullarton, John R ^c   Ferdynus, Cyril ^d   Gouyon, Jean Bernard ^e  

^a HOSPITAL CLÍNIC   (Spain)

^b Children's Hospital Colorado   (United States)

^c Strategen Limited   (United Kingdom)

^d HÔPITAL DU BOCAGE   (France)

^e DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

Hospitalization; immunoprophylaxis; predictive model validation; premature infants; respiratory syncytial virus; risk factors

Indexed keywords

ARTICLE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; FLIP MODEL; FRANCE; GESTATIONAL AGE; HOSPITALIZATION; HUMAN; IMMUNOPROPHYLAXIS; INFANT; MATHEMATICAL MODEL; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RISK FACTOR; VALIDATION STUDY;

CASE-CONTROL STUDIES; DATABASES, FACTUAL; FEMALE; FRANCE; GESTATIONAL AGE; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; MODELS, BIOLOGICAL; PREGNANCY; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RISK FACTORS;

EID: 77954601344     PISSN: 03005577     EISSN: 16193997     Source Type: Journal    
DOI: 10.1515/JPM.2010.074     Document Type: Article

References (21)

1. Altman DG, Bland JM. Diagnostic tests 2: predictive values. Statistical notes. Br Med J. 1994;309:102.
2. Bradley JP, Bacharier LB, Bonfiglio J, Schechtman KB, Strunk R, Storch G, et al. Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy. Pediatrics. 2005;115:e7-14. (Pubitemid 43046257)
3. Commission de la Transparence, République Française. 19 décembre 2007. Synagis®.
4. Deeks JJ, Altman DG. Diagnostic tests 4: likelihood ratios. Statistical notes. Br Med J. 2004;329:168-169
5. El-Haijje MJ, Noulin F, de Suremain N, Marc E, Cosnes-Lambe C, Pons-Catalano C, et al. Respiratory syncytial virus in hospitalized children. A 3 year study. Presse Med. 2008; 37:37-43.
6. Figueras-Aloy J, Carbonell-Estrany X, Quero J. Case-control study of the risk factors linked to respiratory syncytial virus infection requiring hospitalisation in premature infants born at a gestational age of 33-35 weeks in Spain. Pediatr Infect Dis J. 2004;23:815-820
7. Figueras-Aloy J, Carbonell-Estrany X, Quero-Jiménez J, Fernández-Colomer B, Guzmán-Cabañas J, Echaniz-Urcelay I, et al. FLIP-2 study: risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks. Pediatr Infect Dis J. 2008;27:788-793
8. Fisher RA. The use of multiple measurements in taxonomic problems. Ann Eugenic. 1936;7:179-188
9. Grimaldi M, Cornet B, Milou C, Gouyon JB. wProspective regional study of an epidemic of respiratory syncytial virus (RSV) bronchiolitisx. wArticle in Frenchx. Arch Pediatr. 2002;9:572-580
10. Impact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics. 1998;102:531-537
11. Law BJ, Langley JM, Allen U, Paes B, Lee DSC, Mitchell I, et al. The pediatric investigators collaborative network on infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation. Pediatr Infect Dis J. 2004;23:806-814
12. Liese JG, Grill E, Fischer B, Roeckl-Wiedmann I, Carr D, Belohradsky BH, The Munich RSV Study Group. Incidence and risk factors of respiratory syncytial virus-related hospitalizations in premature infants in Germany. Eur J Pediatr. 2003;162:230-236
13. Simões EAF. Respiratory syncytial virus. Lancet. 1999; 354:847-852
14. Simões EAF. Immunoprophylaxis of respiratory syncytial virus: global experience. Resp Res. 2002;3(Suppl 1):S26-33.
15. Simões EAF. Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease. J Pediatr. 2003;143:S118-26.
16. Simões EAF. Maternal smoking, asthma, and bronchiolitis: clear-cut association or equivocal evidence? Pediatrics. 2007;119:1210-1212
17. Simões EAF, Carbonell-Estrany X, Fullarton JR, Liese JG, Figueras-Aloy J, Doering G, et al. A predictive model for respiratory syncytial virus (RSV) hospitalisation of premature infants born at 33-35 weeks of gestational age, based on data from the Spanish FLIP study. Resp Res. 2008;9:78.
18. SPSS Inc. 444 N. Michigan Avenue, Chicago, IL 60611.
19. Stensballe LG, Kristensen K, Simões EAF, Jensen H, Nielsen J, Stabell Benn C, et al., for the Danish RSV Data Network. Atopic disposition, wheezing, and subsequent respiratory syncytial virus hospitalization in Danish children younger than 18 months: a nested case-control study. Pediatrics. 2006; 118:1360-1368
20. Von Linstow ML, Hogh M, Nordbo SA, Eugen-Olsen J, Koch A, Hogh B. A community study of clinical traits and risk factors for human metapneumovirus and respiratory syncytial virus infection during the first year of life. Eur J Pediatr. 2008;167:1125-1133
21. WHO. Acute Respiratory Infections Update 2009. www.who.int/vaccine- research/diseases/ari/en/index2.html. Date last updated: September 2009. Date last accessed: September 2009.